Market Overview:
The global diagnostic reagent market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of chronic diseases, rising demand for early diagnosis and treatment, and technological advancements in diagnostics. In addition, growing awareness about preventive healthcare is also contributing to the growth of the market. Based on type, the global diagnostic reagent market is segmented into in vivo diagnostic reagents and in vitro diagnostic reagents. In vivo diagnostic reagents are further classified into immunoassay methods, PCR (polymerase chain reaction), cytokine examination, myocardial infarction detection, eugenics detection (TORCH), and other tests. Immunoassay methods are further sub-segmented into ELISA (enzyme-linked immunosorbent assay), Western blotting assay (WB), radioimmunoassay (RIA) and chemiluminescence immunoassays (CLIA). and others cytokines examination kits .
Product Definition:
A diagnostic reagent is a substance used to identify or measure the presence of another substance. Diagnostic reagents are important because they can help doctors determine what is wrong with a patient and how to best treat them.
In Vivo Diagnostic Reagents:
In Vivo diagnostic reagents are used for the detection of disease-causing microorganisms, chemical compounds or other foreign objects in biological systems. The global in vivo diagnostic reagents market is expected to witness significant growth over the forecast period owing to increasing demand for early diagnosis and growing R&D activities by major industry players.
The development of new technologies such as high-resolution ultrasound imaging.
In Vitro Diagnostic Reagents:
In Vitro Diagnostic Reagents are the specialized formulations used in diagnostic procedures. These formulations help medical practitioners to obtain and analyze various biological samples such as urine, blood, serum, plasma & tissue samples. The IVD reagents market is segmented on the basis of product types into consumables and instruments.
Application Insights:
The endocrine examination segment dominated the global diagnostic reagent market in 2017. Endocrine disorders include diabetes, thyroid, and hormones. The increasing prevalence of these disorders is one of the major factors driving this segment. For instance, according to a study published by WHO in 2018, it was found that about 1 billion people have diabetes globally and about 23 million people are diagnosed with the disease every year. In addition, another study states that about 90% of all diabetic patients suffer from hypothyroidism or hyperthyroidism at some point during their lifetime while 10-15% are suffering from both simultaneously which leads to an increased demand for diagnosis for such conditions during early stages when treatment is easier compared to later stages when it becomes difficult due to advanced stage of disease progression thus propelling growth further.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of diagnostic laboratories, increasing prevalence of chronic diseases, and high adoption rate for advanced technologies in this region. Asia Pacific is expected to witness lucrative growth during the forecast period owing to rising healthcare expenditure and improving infrastructure in this region. Moreover, an increase in awareness about early diagnosis will drive regional market growth over the forecast period.
The key countries contributing towards revenue generation from North America are as follows: U.S.
Growth Factors:
- Increasing incidence of lifestyle diseases such as diabetes and cancer is expected to drive the demand for diagnostic reagents over the forecast period.
- Rising awareness about early diagnosis and treatment of various diseases is also anticipated to propel the market growth.
- Technological advancements in diagnostic reagents are projected to create new opportunities for market players over the next few years.
- Growing demand from emerging economies is another key factor that would fuel the growth of this market in near future.
Scope Of The Report
Report Attributes
Report Details
Report Title
Diagnostic Reagent Market Research Report
By Type
In Vivo Diagnostic Reagents, In Vitro Diagnostic Reagents
By Application
Endocrine Examination, Tumor Detection, Detection of Infectious Diseases, Immunoassay Method, Cytokine Examination, Myocardial Infarction Detection, PCR, Eugenics Detection (TORCH), Other,
By Companies
Roche, Siemens, Abbott, Danaher, Thermo Fisher, BioMerieux, Bio-Rad, BD, JNJ, Sysmex, KHB, DaAn Gene, Leadman, BioSino, BSBE, Maccura,
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Diagnostic Reagent Market Report Segments:
The global Diagnostic Reagent market is segmented on the basis of:
Types
In Vivo Diagnostic Reagents, In Vitro Diagnostic Reagents
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Endocrine Examination, Tumor Detection, Detection of Infectious Diseases, Immunoassay Method, Cytokine Examination, Myocardial Infarction Detection, PCR, Eugenics Detection (TORCH), Other,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- Siemens
- Abbott
- Danaher
- Thermo Fisher
- BioMerieux
- Bio-Rad
- BD
- JNJ
- Sysmex
- KHB
- DaAn Gene
- Leadman
- BioSino
- BSBE
- Maccura
Highlights of The Diagnostic Reagent Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- In Vivo Diagnostic Reagents
- In Vitro Diagnostic Reagents
- By Application:
- Endocrine Examination
- Tumor Detection
- Detection of Infectious Diseases
- Immunoassay Method
- Cytokine Examination
- Myocardial Infarction Detection
- PCR
- Eugenics Detection (TORCH)
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Diagnostic Reagent Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A diagnostic reagent is a chemical or biological agent that can be used to identify the presence of a particular disease or condition. Diagnostic reagents are often used in medical testing and diagnosis.
Some of the major companies in the diagnostic reagent market are Roche, Siemens, Abbott, Danaher, Thermo Fisher, BioMerieux, Bio-Rad, BD, JNJ, Sysmex, KHB, DaAn Gene, Leadman, BioSino, BSBE, Maccura.
The diagnostic reagent market is expected to grow at a compound annual growth rate of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Diagnostic Reagent Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Diagnostic Reagent Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Diagnostic Reagent Market - Supply Chain
4.5. Global Diagnostic Reagent Market Forecast
4.5.1. Diagnostic Reagent Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Diagnostic Reagent Market Size (000 Units) and Y-o-Y Growth
4.5.3. Diagnostic Reagent Market Absolute $ Opportunity
5. Global Diagnostic Reagent Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Diagnostic Reagent Market Size and Volume Forecast by Type
5.3.1. In Vivo Diagnostic Reagents
5.3.2. In Vitro Diagnostic Reagents
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Diagnostic Reagent Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Diagnostic Reagent Market Size and Volume Forecast by Application
6.3.1. Endocrine Examination
6.3.2. Tumor Detection
6.3.3. Detection of Infectious Diseases
6.3.4. Immunoassay Method
6.3.5. Cytokine Examination
6.3.6. Myocardial Infarction Detection
6.3.7. PCR
6.3.8. Eugenics Detection (TORCH)
6.3.9. Other
6.3.10.
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Diagnostic Reagent Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Diagnostic Reagent Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Diagnostic Reagent Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Diagnostic Reagent Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Diagnostic Reagent Demand Share Forecast, 2019-2026
9. North America Diagnostic Reagent Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Diagnostic Reagent Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Diagnostic Reagent Market Size and Volume Forecast by Application
9.4.1. Endocrine Examination
9.4.2. Tumor Detection
9.4.3. Detection of Infectious Diseases
9.4.4. Immunoassay Method
9.4.5. Cytokine Examination
9.4.6. Myocardial Infarction Detection
9.4.7. PCR
9.4.8. Eugenics Detection (TORCH)
9.4.9. Other
9.4.10.
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Diagnostic Reagent Market Size and Volume Forecast by Type
9.7.1. In Vivo Diagnostic Reagents
9.7.2. In Vitro Diagnostic Reagents
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Diagnostic Reagent Demand Share Forecast, 2019-2026
10. Latin America Diagnostic Reagent Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Diagnostic Reagent Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Diagnostic Reagent Market Size and Volume Forecast by Application
10.4.1. Endocrine Examination
10.4.2. Tumor Detection
10.4.3. Detection of Infectious Diseases
10.4.4. Immunoassay Method
10.4.5. Cytokine Examination
10.4.6. Myocardial Infarction Detection
10.4.7. PCR
10.4.8. Eugenics Detection (TORCH)
10.4.9. Other
10.4.10.
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Diagnostic Reagent Market Size and Volume Forecast by Type
10.7.1. In Vivo Diagnostic Reagents
10.7.2. In Vitro Diagnostic Reagents
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Diagnostic Reagent Demand Share Forecast, 2019-2026
11. Europe Diagnostic Reagent Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Diagnostic Reagent Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Diagnostic Reagent Market Size and Volume Forecast by Application
11.4.1. Endocrine Examination
11.4.2. Tumor Detection
11.4.3. Detection of Infectious Diseases
11.4.4. Immunoassay Method
11.4.5. Cytokine Examination
11.4.6. Myocardial Infarction Detection
11.4.7. PCR
11.4.8. Eugenics Detection (TORCH)
11.4.9. Other
11.4.10.
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth rojections by Application
11.7. Europe Diagnostic Reagent Market Size and Volume Forecast by Type
11.7.1. In Vivo Diagnostic Reagents
11.7.2. In Vitro Diagnostic Reagents
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Diagnostic Reagent Demand Share, 2019-2026
12. Asia Pacific Diagnostic Reagent Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Diagnostic Reagent Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Diagnostic Reagent Market Size and Volume Forecast by Application
12.4.1. Endocrine Examination
12.4.2. Tumor Detection
12.4.3. Detection of Infectious Diseases
12.4.4. Immunoassay Method
12.4.5. Cytokine Examination
12.4.6. Myocardial Infarction Detection
12.4.7. PCR
12.4.8. Eugenics Detection (TORCH)
12.4.9. Other
12.4.10.
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Diagnostic Reagent Market Size and Volume Forecast by Type
12.7.1. In Vivo Diagnostic Reagents
12.7.2. In Vitro Diagnostic Reagents
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Diagnostic Reagent Demand Share, 2019-2026
13. Middle East & Africa Diagnostic Reagent Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Diagnostic Reagent Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Diagnostic Reagent Market Size and Volume Forecast by Application
13.4.1. Endocrine Examination
13.4.2. Tumor Detection
13.4.3. Detection of Infectious Diseases
13.4.4. Immunoassay Method
13.4.5. Cytokine Examination
13.4.6. Myocardial Infarction Detection
13.4.7. PCR
13.4.8. Eugenics Detection (TORCH)
13.4.9. Other
13.4.10.
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Diagnostic Reagent Market Size and Volume Forecast by Type
13.7.1. In Vivo Diagnostic Reagents
13.7.2. In Vitro Diagnostic Reagents
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Diagnostic Reagent Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Diagnostic Reagent Market: Market Share Analysis
14.2. Diagnostic Reagent Distributors and Customers
14.3. Diagnostic Reagent Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Roche
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Siemens
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Abbott
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Danaher
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Thermo Fisher
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. BioMerieux
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Bio-Rad
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. BD
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. JNJ
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Sysmex
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. KHB
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. DaAn Gene
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Leadman
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. BioSino
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. BSBE
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Maccura
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17.
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
